NASDAQ
4D Molecular Therapeutics, Inc. (FDMT) has a current ratio of 9.39x as of Monday, May 25, 2026. This represents a 37.67% decrease compared to its 12-month average of 15.07x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.